SAVE THE DATE - ACRP.be European Conference - 18th October 2018 - Media House in Groot-Bijgaarden, Belgium Confirmed Speakers: Greet Musch – FAMPH, Mieke Roelants - genae, Patrick Cras - Universiteit Antwerpen, Josse Thomas - Universiteit Antwerpen, Bart Hartog – Janssen, Philippe Lemaitre - The Silver Ones, Daniel De Schryver - J&J Preliminary topics: - Latest EU clinical trial updates from a pharma and medical device point of view - Impact European Regulation and GDPR - Ethical payment perspective - Decentralized clinical trials - The patient perspective Subscription will be opened soon – stay tuned. Looking forward to meet you at the Yearly Conference!
Dimitri H.J. Buytaert’s Post
More Relevant Posts
-
LAST chance to register for our Webcast. Dr. Carl June and Christopher Ung will engage in an insightful fireside chat-style discussion on the challenges and future trends in the CAR T-cell therapy space, including: Academic and Industry Partnership in CAR-T Development; CAR-T Development in US and China; Biomarkers from Vein to Vein: Mechanism, Selection, and Resistance; Facing the Challenges: Adverse Events and Patient Resistance; New Frontiers: Solid Tumors, Evolutionary and Revolutionary CAR models. You get the opportunity to submit questions on registration. This is a fantastic chance to get answers on topical questions in the CAR-T space from a pioneer and leader in the field. Here’s the link to register: https://bit.ly/3Urva6p
All six CAR-T cell therapies to date were approved for treating B-cell hematologic cancers. What does that mean for the future of CAR-T cell therapy in solid tumors? Join Dr. Carl June, pioneer in the field of CAR-T, in conversation with Christopher Ung, our Chief Scientific Business Officer as they discuss new frontiers in CAR-T cell therapy including new models and treating solid tumors. Register here to reserve your spot and submit a question for our speakers: https://bit.ly/3Hpo1f1 #CART #CellTherapy #PrecisionMedicine
To view or add a comment, sign in
-
Healixia - the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy - Join us at the end of spring for an informal get-together, where you can meet long-known and new peers over some good food and drinks.
This content isn’t available here
Access this content and more in the LinkedIn app
To view or add a comment, sign in
-
CellCarta acquisition of Biogazelle #cellcarta; #biogazelle CellCarta has completed the acquisition of Biogazelle, a specialty CRO with a focus on nucleic acid quantification service for preclinical and clinical development. The company has a team of 45 full-time employees and is located in Ghent, Belgium in a facility of 750 m2. The addition of Biogazelle to the CellCarta family allows us to expand our existing genomic capabilities with high-end digital PCR, and strengthen our quantitative PCR and RNAseq assays. While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta’s Center of Excellence for the development of complex genomic biomarker assays. The acquisition allows CellCarta to expand its offering to clients in fields with high demand in genomic analysis, such as immuno-oncology and cell and gene therapy. Biogazelle has high scientific expertise and is internationally recognized for setting standards in gene expression analysis. We’re very excited to welcome them to our team!
To view or add a comment, sign in
-
Don't miss out the Healixia Annual Conference - NOVEMBER 23rd. 'Current and future trends in patient centric solutions for healthcare'. You will appreciate the final program with following distinguished speakers: Noël Wathion (former Deputy Executive Director EMEA), Stefanie Veraghtert, Benoit Brouwers - #healthcare #clinicalresearch
To view or add a comment, sign in
-
Do you know Healixia? Founded in 2020, and with 600+ members: we are the largest community for professionals in the Belgian health eco-system. Our professionals are active in early development, clinical research, regulatory affairs and medical affairs. More info on www.healixia.be #clinicalresearch #regulatoryaffairs
To view or add a comment, sign in
-
PRESS RELEASE: We’re excited to announce the acquisition of Reveal Biosciences a leading company that combines computational histopathology with #AI pathology solutions. For more information: https://bit.ly/3vWilS1 #CellCarta #CROlaboratory #biomarkers #precisionmedicine #digitalpathology
To view or add a comment, sign in
-
Happy to announce the next big step in the growth of Caprion-HistoGeneX. We are rebranding as CellCarta, your partner of choice for Precision Medicine laboratory services. #CellCarta #precisionmedicine
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
To view or add a comment, sign in
-
Let's connect! #Healixia
Instead of the Annual Symposium, Healixia - let's connect - is organising a number of webinars this autumn. Below you will find a first interesting webinar for which you can register here: https://lnkd.in/d9JFXwU. These webinars are free for our Healixia members!
To view or add a comment, sign in